Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID. Chapuis-Biron C, Kirchgesner J, Pariente B, Bouhnik Y, et al. Am J Gastroenterol 2020;115:1812-1820.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chapuis-Biron C, Kirchgesner J, Pariente B, Bouhnik Y, et al. Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID. Am J Gastroenterol 2020;115:1812-1820.
PMID: 33156100